Please note: a valid prescription is required for all prescription medication.
Baraclude® Tablets for Chronic Hepatitis B
$919.99
Secure Encrypted Payments
What Baraclude® Is and How It Works
Baraclude (entecavir) is an oral antiviral for chronic hepatitis B. It is a potent nucleoside analogue that targets the hepatitis B virus DNA polymerase. Many patients use it long term to maintain viral suppression and protect liver health. If comparing Baraclude price, our Canadian option helps reduce costs, including for those buying Baraclude without insurance. You can buy Baraclude online through our secure checkout once a valid prescription is uploaded.
Youdrugstore is a licensed Canadian pharmacy headquartered in Manitoba; prescriptions are reviewed by licensed pharmacists before dispensing.
Entecavir is phosphorylated to an active triphosphate and competes with deoxyguanosine. It blocks priming, reverse transcription, and viral DNA strand synthesis. This action lowers HBV DNA, improves ALT, and supports serologic responses over time.
Baraclude comes as film‑coated tablets and an oral solution. The usual regimen is once daily on an empty stomach. Clinical decisions on dose and duration depend on viral status, prior nucleoside exposure, and liver function.
Dosage and Usage
- Typical adult dose for nucleoside‑naive: 0.5 mg once daily on an empty stomach (at least 2 hours after a meal and 2 hours before the next meal).
- Lamivudine‑resistant or decompensated liver disease: 1 mg once daily on an empty stomach.
- Renal impairment: dose adjustment is required based on creatinine clearance.
- Oral solution delivers the same daily dose in mL; use the provided measuring device.
- Swallow tablets whole with water; do not crush unless instructed by a pharmacist.
- Missed dose: take as soon as remembered unless it is close to the next dose; do not double doses.
- Do not stop therapy unless directed by the prescriber due to risk of hepatitis flares.
- Store tablets at 20–25°C (68–77°F); short excursions 15–30°C (59–86°F) are acceptable.
- Keep in the original bottle with the desiccant; protect from moisture.
- For the oral solution, store at room temperature; do not freeze.
- When traveling, keep Baraclude in your carry‑on with your prescription label.
- Avoid leaving medicine in a hot car; use a small insulated pouch if needed.
- Set phone reminders so you take each dose on time.
- Order refills a bit early to avoid running out during trips.
Benefits and Savings
Baraclude shows strong antiviral efficacy across HBeAg‑positive and HBeAg‑negative disease. It achieves rapid HBV DNA reduction and supports ALT normalization as adherence continues. Resistance is uncommon in nucleoside‑naive patients. Once‑daily dosing and an oral solution option make ongoing treatment straightforward.
Buying through a Canadian pharmacy often brings 60–80% savings compared with typical U.S. prices. That helps lower the Baraclude cost for many patients, including those paying without insurance. Generic entecavir can further reduce the monthly expense while maintaining the same active ingredient and strength.
We work with licensed, vetted international partner pharmacies to source authentic brand medications and generics, offering broad choice at affordable pricing.
For extra value, check current promotions. See the Baraclude coupon options available.
Side Effects and Safety
- Common effects: headache, fatigue, dizziness, nausea, diarrhea, indigestion.
- Less common: insomnia, somnolence, rash, increased liver enzymes.
- Laboratory changes: transient ALT rises may occur, especially after changes in therapy.
Serious risks are rare but include lactic acidosis and severe hepatomegaly with steatosis. Severe acute exacerbations of hepatitis B have been reported after treatment discontinuation; monitoring is essential if therapy stops. In HBV/HIV co‑infection, entecavir may select for HIV resistance without a fully suppressive antiretroviral regimen. Dose adjustments are needed in renal impairment. Discuss pregnancy, breastfeeding, and transplant status with the prescriber.
Onset Time
HBV DNA often falls within the first 2–4 weeks as steady‑state levels are reached. ALT improvements usually appear over 8–12 weeks. Serologic responses, such as HBeAg loss or seroconversion, can take months and are assessed at routine follow‑ups. Fibrosis benefits are gradual and depend on long‑term viral suppression.
If therapy is interrupted, flares can occur, so continuity and monitoring are important. Many patients remain on treatment for years based on clinical goals and guideline criteria.
Compare With Alternatives
Tenofovir disoproxil fumarate (TDF) is a first‑line HBV agent with high potency and a high barrier to resistance. It may affect renal function and bone mineral density in some patients, so monitoring is routine.
Tenofovir alafenamide (TAF) provides similar antiviral efficacy to TDF with less impact on kidneys and bone markers in studies. It is a strong option when renal or bone safety is a concern.
Lamivudine is effective initially but has a lower barrier to resistance. For lamivudine‑resistant patients, entecavir at 1 mg daily or a tenofovir‑based regimen is often used to regain control.
Combination Therapy
- Specialists may combine entecavir with a tenofovir formulation for resistant virus or advanced disease.
- Avoid overlapping nucleos(t)ide analogues without expert guidance due to resistance concerns.
- In HIV/HBV co‑infection, use within a fully suppressive antiretroviral regimen to prevent HIV resistance.
- Adjust HBV therapy if renal function changes to keep exposure appropriate.
Patient Suitability and Cost-Saving Tips
Baraclude is used for adults and certain pediatric patients with chronic HBV and evidence of viral replication. It is considered in both HBeAg‑positive and HBeAg‑negative disease. Those with renal impairment need tailored dosing, and those with decompensated cirrhosis require close monitoring.
People with HBV/HIV co‑infection should not receive entecavir without a complete antiretroviral regimen. Caution applies in pregnancy and breastfeeding; prescribers weigh benefits and risks. Report any history of lactic acidosis, significant liver disease events, or hypersensitivity to entecavir excipients.
To manage expense, consider a multi‑month supply to lower the per‑month Baraclude tablets price. Reorder reminders help maintain therapy continuity. Generic entecavir offers a lower Baraclude generic cost with the same active ingredient. Patients paying out of pocket can compare the Baraclude cash price and choose the best option for their budget.
Authoritative Sources
Baraclude (entecavir) US Prescribing Information – Bristol Myers Squibb
Health Canada Drug Product Database – Entecavir (Baraclude)
FDA Label and Medication Guide – Entecavir
Order Baraclude® from Youdrugstore: add to cart, upload your prescription, and we ship with prompt, express, cold-chain handling.
This content is educational and does not replace advice from your healthcare professional. Always follow your prescriber’s directions and the dispensing pharmacist’s counsel.
Express Shipping - from $25.00
Shipping with this method takes 3-5 days
Prices:
- Dry-Packed Products $25.00
- Cold-Packed Products $35.00
Shipping Countries:
- United States (all contiguous states**)
- Worldwide (excludes some countries***)
Standard Shipping - $15.00
Shipping with this method takes 5-10 days
Prices:
- Dry-Packed Products $15.00
- Not available for Cold-Packed products
Shipping Countries:
- United States (all contiguous states**)
- Worldwide (excludes some countries***)
What is Baraclude and how does it work?
Baraclude (entecavir) is an oral antiviral for chronic hepatitis B. It is a nucleoside analogue that inhibits HBV DNA polymerase, blocking viral DNA synthesis. This reduces HBV DNA levels, improves liver enzymes, and supports long‑term viral suppression when taken as directed under medical supervision.
How quickly does Baraclude start working?
HBV DNA often declines within 2–4 weeks of starting therapy, with ALT improvements over 8–12 weeks. Serologic changes, like HBeAg loss or seroconversion, take longer and are evaluated during follow‑up visits. Overall timelines vary by baseline viral load, prior treatments, adherence, and liver status.
What are common Baraclude side effects?
Common side effects include headache, fatigue, dizziness, nausea, diarrhea, and indigestion. Less common effects are insomnia, sleepiness, rash, and transient increases in liver enzymes. Serious events are rare but include lactic acidosis and severe liver enlargement with steatosis; seek urgent care for alarming symptoms.
How is Baraclude usually taken?
The typical adult dose is 0.5 mg once daily for nucleoside‑naive patients and 1 mg daily for lamivudine‑resistant or decompensated disease. It is taken on an empty stomach, at least two hours after a meal and two hours before the next meal. Dose adjustments are needed in renal impairment.
How can I save on Baraclude without insurance?
Canadian pharmacy pricing can reduce costs by 60–80% versus typical U.S. prices. Compare Baraclude price options for brand and generic entecavir. Multi‑month supplies often lower the monthly cost. Ordering early helps avoid urgent shipments. Promotions change over time, so check for current offers before purchasing.
Is a generic version of Baraclude available?
Yes. Generic entecavir contains the same active ingredient and strengths as Baraclude. It is taken once daily and is considered therapeutically equivalent. Many patients choose the generic to lower the Baraclude prescription cost while maintaining the same antiviral effect and clinical monitoring schedule.
What happens if Baraclude is stopped abruptly?
Stopping entecavir can cause severe flares of hepatitis B. Clinicians monitor patients closely if therapy is discontinued or changed, with frequent labs and symptom checks. Any decision to stop is made by the prescriber, and a plan is set to manage the risk of rebound hepatitis.
